JP2015522049A5 - - Google Patents

Download PDF

Info

Publication number
JP2015522049A5
JP2015522049A5 JP2015520915A JP2015520915A JP2015522049A5 JP 2015522049 A5 JP2015522049 A5 JP 2015522049A5 JP 2015520915 A JP2015520915 A JP 2015520915A JP 2015520915 A JP2015520915 A JP 2015520915A JP 2015522049 A5 JP2015522049 A5 JP 2015522049A5
Authority
JP
Japan
Prior art keywords
weight
formulation
amount
alcohol
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015520915A
Other languages
English (en)
Japanese (ja)
Other versions
JP6259454B2 (ja
JP2015522049A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/064123 external-priority patent/WO2014009241A1/en
Publication of JP2015522049A publication Critical patent/JP2015522049A/ja
Publication of JP2015522049A5 publication Critical patent/JP2015522049A5/ja
Application granted granted Critical
Publication of JP6259454B2 publication Critical patent/JP6259454B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015520915A 2012-07-12 2013-07-04 ジクロフェナク製剤 Active JP6259454B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12176115 2012-07-12
EP12176115.9 2012-07-12
PCT/EP2013/064123 WO2014009241A1 (en) 2012-07-12 2013-07-04 Diclofenac formulations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017182383A Division JP6434104B2 (ja) 2012-07-12 2017-09-22 ジクロフェナク製剤

Publications (3)

Publication Number Publication Date
JP2015522049A JP2015522049A (ja) 2015-08-03
JP2015522049A5 true JP2015522049A5 (enExample) 2016-06-16
JP6259454B2 JP6259454B2 (ja) 2018-01-10

Family

ID=48741196

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015520915A Active JP6259454B2 (ja) 2012-07-12 2013-07-04 ジクロフェナク製剤
JP2017182383A Active JP6434104B2 (ja) 2012-07-12 2017-09-22 ジクロフェナク製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017182383A Active JP6434104B2 (ja) 2012-07-12 2017-09-22 ジクロフェナク製剤

Country Status (14)

Country Link
US (2) US9999590B2 (enExample)
EP (2) EP3275466A1 (enExample)
JP (2) JP6259454B2 (enExample)
KR (1) KR20150030752A (enExample)
CN (1) CN104428003B (enExample)
AU (1) AU2013289403B2 (enExample)
BR (1) BR112015000329A2 (enExample)
CA (1) CA2878784A1 (enExample)
HK (1) HK1204973A1 (enExample)
IL (1) IL236304A0 (enExample)
MX (1) MX2015000541A (enExample)
NZ (1) NZ702967A (enExample)
RU (1) RU2014152445A (enExample)
WO (1) WO2014009241A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10813897B2 (en) * 2011-12-27 2020-10-27 Cmpd Licensing, Llc Composition and method for compounded therapy
NZ702967A (en) * 2012-07-12 2017-07-28 Ferring Bv Diclofenac formulations
US9855234B2 (en) * 2014-07-08 2018-01-02 Insys Development Company, Inc. Diclofenac sublingual spray
JP7069042B2 (ja) 2016-12-28 2022-05-17 久光製薬株式会社 貼付剤
JP7109093B2 (ja) * 2017-01-31 2022-07-29 帝國製薬株式会社 リドカインおよびジクロフェナクを含む医薬用貼付剤についての投与計画
JP7250689B2 (ja) * 2017-03-07 2023-04-03 イッサム・リサーチ・ディベロップメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシティ・オブ・エルサレム・リミテッド 活性化合物のための局所送達系
KR20190101140A (ko) * 2018-02-22 2019-08-30 동아제약 주식회사 비스테로이드성 소염진통 활성성분을 함유하는 필름 형성 약제학적 조성물
JP7053790B2 (ja) 2018-02-27 2022-04-12 久光製薬株式会社 ジクロフェナク含有乳化ゲル組成物
US20210386858A1 (en) * 2019-02-19 2021-12-16 Bluepharma - Industria Farmacêutica, S.A. Mucoadhesive compositions and uses thereof
JP6744512B1 (ja) * 2020-02-12 2020-08-19 久光製薬株式会社 ジクロフェナクナトリウム含有貼付剤
JP6761553B1 (ja) * 2020-02-12 2020-09-23 久光製薬株式会社 ジクロフェナクナトリウム含有貼付剤
BR112022016887A2 (pt) 2020-02-27 2022-10-18 Ferring Bv Composições tópicas de diclofenaco e métodos
JP2022096994A (ja) * 2020-12-18 2022-06-30 小林製薬株式会社 外用医薬組成物
US11872320B2 (en) 2021-02-25 2024-01-16 Hisamitsu Pharmaceutical Co., Inc. Method for treating osteoarthritis
IT202100016751A1 (it) * 2021-06-25 2022-12-25 Altergon Sa Formulazione topica di diclofenac ad elevato tasso di assorbimento
JP2024538604A (ja) 2021-10-01 2024-10-23 ニュートリション・アンド・バイオサイエンシーズ・ユーエスエー・ワン,エルエルシー 局所適用のための親水コロイドブレンド組成物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803871D0 (sv) 1998-11-11 1998-11-11 Pharmacia & Upjohn Ab Therapeutic method and formulation
US20070225379A1 (en) * 2001-08-03 2007-09-27 Carrara Dario Norberto R Transdermal delivery of systemically active central nervous system drugs
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
MY148466A (en) 2001-10-26 2013-04-30 Merck Frosst Canada Ltd Granule formulation
GB0210397D0 (en) 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
PE20040321A1 (es) 2002-08-22 2004-07-15 Novartis Consumer Health Sa Composicion topica que comprende diclofenaco
US20040096569A1 (en) 2002-11-15 2004-05-20 Barkalow David G. Edible film products and methods of making same
EP1428526A1 (en) 2002-12-13 2004-06-16 Rijksuniversiteit Groningen Formulation for fast dissolution of lipophilic compounds
PL1670433T3 (pl) 2003-10-10 2013-03-29 Ferring Bv Przezskórna formulacja farmaceutyczna do zmniejszania pozostałości na skórze
US8158152B2 (en) 2005-11-18 2012-04-17 Scidose Llc Lyophilization process and products obtained thereby
GB0524958D0 (en) 2005-12-07 2006-01-18 Pharmakodex Ltd Transdermal administration of active agents
DK2347775T3 (da) 2005-12-13 2020-07-13 Harvard College Skabeloner til celletransplantation
TW200815045A (en) 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
EP2055298A1 (en) * 2007-10-30 2009-05-06 Novartis AG Topical composition
US8623401B2 (en) 2008-03-27 2014-01-07 Fenwafe Inc. Wafer formulation
EP2364140A1 (en) 2008-11-28 2011-09-14 Advance Holdings Limited Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester
KR20110127678A (ko) 2009-03-11 2011-11-25 코와 가부시키가이샤 진통·항염증제 함유 외용제
EP2552418B1 (en) 2010-03-29 2017-08-09 Ferring B.V. A fast dissolving pharmaceutical composition
NZ702967A (en) * 2012-07-12 2017-07-28 Ferring Bv Diclofenac formulations

Similar Documents

Publication Publication Date Title
JP2015522049A5 (enExample)
RU2014152445A (ru) Композиции на основе диклофенака
JP2014503565A5 (enExample)
AU2013359392C1 (en) Compositions and methods for tissue regeneration
WO2009053741A3 (en) Novel formulation
JP2014530242A5 (enExample)
RU2013133082A (ru) Композиции тестостерона
ECSP045140A (es) Formulaciones farmacéuticas derivadas del platino
JP2013515002A5 (enExample)
RU2015122627A (ru) Кожные композиции, содержащие неприродные гигроскопические аминокислоты
EA201590591A1 (ru) Способ приготовления геля на основе полифенолов гранатовой кожуры для лечения воспалительных заболеваний в гинекологии
JP2012525358A5 (enExample)
US9078869B2 (en) Method for treating skin inflammatory diseases
WO2024088153A1 (zh) 托品酸及其衍生物在制备治疗银屑病药物中的用途
CN101433544B (zh) 具有抗炎消肿镇痛作用的外用药物组合物制剂与用途
EP3294267A1 (en) Compositions for treating and/or preventing psoriasis, prickly heat, dermatitises, neurofibromatosis type 1 and other pathologies of the dermis, mucosae, and oral cavity
ITBS20120093A1 (it) Composizione cosmetica e/o farmaceutica per il trattamento dell'infiammazione della cute e delle sindromi correlate
NZ606177A (en) Compositions for the treatment of actinic keratosis
RU2016101152A (ru) Терапевтические агенты для применения в профилактике и/или лечении гиперкинетических двигательных расстройств
TW201622712A (zh) 外用醫藥組成物
TW201632182A (zh) 治療皮膚之腫瘤及癌前病理的雷公藤內酯及其衍生物
JP6477005B2 (ja) 角層水分量の低下抑制剤
CN106413699B (zh) 外用药物组合物
CN101803961B (zh) 鱼用创可贴
US8877185B2 (en) Managing and treating keloids